DCTH Key Stats
|Revenue (Quarterly YoY Growth)||84.62%|
|EPS Diluted (TTM)||-0.4229|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-36.19M|
|Gross Profit Margin (Quarterly)||68.06%|
|Profit Margin (Quarterly)||-10008%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Nov 18
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 12
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh Nov 7
- Delcath Systems' CEO Discusses Q3 2013 Results - Earnings Call Transcript Seeking Alpha Nov 6
- Delcath Reports 2013 Third Quarter Results noodls Nov 6
- DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report Nov 6
- Delcath Systems, Inc. (DCTH) Tops Q3 EPS by 1c Street Insider Nov 6
- Delcath Systems, Inc. Earnings Call scheduled for 4:30 pm ET today Nov 6
- Delcath Systems, Inc. Discusses Q3 2013 Results (Webcast) Seeking Alpha Nov 6
- Q3 2013 Delcath Systems, Inc. Earnings Release - After Market Close Nov 6
DCTH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Delcath Systems is down 80.73% over the last year vs S&P 500 Total Return up 28.99%, Echo Therapeutics down 66.43%, and Cynosure up 6.44%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for DCTH
Pro Strategies Featuring DCTH
Did Delcath Systems make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Delcath Systems, Inc., is a pharmaceutical and medical device company. It focuses on the treatment of primary and metastatic liver cancers.